Recruiting Neuromyelitis Optica Studies in Dallas
About Neuromyelitis Optica Clinical Trials in Dallas
Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune disease that primarily attacks the optic nerves and spinal cord, causing vision loss and paralysis. It is distinct from multiple sclerosis and often involves aquaporin-4 antibodies. Treatment includes immunosuppressive therapies and biologics.
There are currently 2 neuromyelitis optica clinical trials recruiting participants in Dallas, TX. These studies are seeking a combined 50 participants. Research is being sponsored by University of Texas Southwestern Medical Center, Amgen. Clinical trial participation is free and participants receive study-related medical care at no cost.
Neuromyelitis Optica Clinical Trials in Dallas — FAQ
Are there neuromyelitis optica clinical trials in Dallas?
Yes, there are 2 neuromyelitis optica clinical trials currently recruiting in Dallas, TX. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Dallas?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Dallas research site will contact you about next steps.
Are clinical trials in Dallas free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Dallas studies also compensate for your time and travel.
What neuromyelitis optica treatments are being tested?
The 2 active trials in Dallas are testing new therapies including novel drugs, biologics, and treatment approaches for neuromyelitis optica.
Data updated October 18, 2026 from ClinicalTrials.gov